B-Cell Targeted Carfilzomib Desensitization

Clinical trial NCT02442648 · UNKNOWN

Trial details

NCT number: NCT02442648
Sponsor: E. Steve Woodle
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Transplants and Implants

Start date: 2014-12-01
Primary completion: 2021-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.